Neovasc to Report Fourth Quarter and Full Year 2021 Financial Results on March 10, 2022
25 February 2022 - 1:00AM
via NewMediaWire – Neovasc Inc. (NASDAQ, TSX: NVCN), will report
financial results for the quarter and full year ended December 31,
2021 on Thursday, March 10, 2022. Neovasc’s President and Chief
Executive Officer Fred Colen, and Chris Clark, Chief Financial
Officer, will host a conference call to review the company’s
results at 4:30 pm EDT on March 10, 2022.
Interested parties may access the conference call by dialing
(877) 407-9208 or (201) 493-6784 (International) and reference
Conference ID 13726770. Participants wishing to join the call via
webcast should use the link posted on the investor relations
section of the Neovasc website at
https://www.neovasc.com/investors/. A replay of the webcast will be
available approximately 30 minutes after the conclusion of the call
using the link on the Neovasc website.
About Neovasc Inc.
Neovasc is a specialty medical device company that develops,
manufactures, and markets products for the rapidly growing
cardiovascular marketplace. Its products include Reducer, for the
treatment of refractory angina, which is under clinical
investigation in the United States and has been commercially
available in Europe since 2015, and Tiara™ for the transcatheter
treatment of mitral valve disease, which is currently under
clinical investigation in the United States, Canada, Israel and
Europe. For more information, visit: www.neovasc.com.
InvestorsMike CavanaughWestwicke/ICRPhone:
+1.617.877.9641Mike.Cavanaugh@westwicke.com
MediaSean LeousWestwicke/ICRPhone:
+1.646.866.4012Sean.Leous@icrinc.com
Neovasc (NASDAQ:NVCN)
Historical Stock Chart
From Jun 2024 to Jul 2024
Neovasc (NASDAQ:NVCN)
Historical Stock Chart
From Jul 2023 to Jul 2024